<DOC>
	<DOCNO>NCT01620684</DOCNO>
	<brief_summary>This project examine whether short-term ( 12-hour period ) pharmacological lower stress hormone 'cortisol ' improves nervous system response food intake overweight obese individual metabolic syndrome . The investigator know previous research overweight/obese person insulin resistant , blunt sympathetic nervous response carbohydrate ingestion . This mean less able dissipate energy caloric intake , would favour maintenance obese state . Cortisol adversely impact insulin action transport brain cortisol level often elevate person central ( abdominal ) obesity . A randomized , double-blind , placebo control , cross-over design use compare effect overnight treatment metyrapone ( 15 mg/kg midnight 15 mg/kg 6 ) versus placebo sympathetic nervous system activity response standard 75-g oral sugar ( glucose ) tolerance test . A 2 week washout separate treatment . Metyrapone drug reversibly inhibit enzyme 11beta-hydroxylase , therefore production cortisol . It use clinically test activity adrenal gland ( key site cortisol production ) pituitary gland . The investigator anticipate dosage use , low blood cortisol concentration 44 64 % experimental morning . The study protocol comprise two screen visit two experimental morning . Key procedure include : - Assessment insulin action ( sensitivity ) use gold standard 'clamp ' method . - Measurement sympathetic nervous system activity biochemical method ( isotope dilution provide measure apparent rate release 'noradrenaline'-the key neurotransmitter sympathetic nervous system ) direct intra-neuronal nerve recording peroneal nerve low leg . - Indirect calorimetry ass rest metabolic rate response sugar ingestion . - DEXA scan quantify fat lean mass . - Assessment arterial elasticity calf blood flow non-invasive method . - A standard 75g oral sugar tolerance test . The result provide important new information regard role cortisol nervous system function overweight/obese individual .</brief_summary>
	<brief_title>Cortisol Nutritional Sympathetic Responsiveness</brief_title>
	<detailed_description>Similarities metabolic syndrome obesity hypercortisolemic condition Cushing 's syndrome raise interest pathogenic role glucocorticoid excess clinical setting . Cortisol well know counter-regulator insulin action increase level serum cortisol link insulin resistance many study . Moreover , treatment synthetic glucocorticoid dexamethasone reduce central nervous system insulin uptake 49 % dog . We previously identify metabolic syndrome subject , inverse relationship morning fast cortisol level sympathetic neural responsiveness oral glucose ingestion . This concur evidence cortisol synthetic glucocorticoid sympathoinhibitory effect . This project test hypothesis short-term lowering plasma cortisol level overnight metyrapone treatment , improve nutritional sympathetic nervous system response carbohydrate ingestion obese insulin resistant subject metabolic syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metyrapone</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>unmedicated , overweight obese subject ( 12 men 12 postmenopausal woman ) , weightstable , nonsmoking , aged 4565 year recruit basis &gt; 3 MetS criterion per newly harmonize definition . elevate waist circumference define &gt; 102 cm men &gt; 88 cm woman . subject also insulin resistant ( HOMA index &gt; 2.5 and/or euglycaemic hyperinsulinemic clamp derive M/I value &lt; 8 mg per kg fat free mass per minute per mU/L x 100 ) . adrenocortical insufficiency , pituitary dysfunction tumour , sleep apnoea treat CPAP , cardiovascular disease ( previous MI , angina , stroke , heart failure , secondary hypertension ) , renal hepatic disease ( serum creatinine &gt; 0.2 mmol/L ; &gt; 1 proteinuria dipstick ; alanine transferase &gt; 2.5 time upper limit normal , active liver disease ) diseases may affect measure parameter ( e.g . thyroid , Cushing 's Addison 's disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>